45 Years of Experience
Affiliated with a Castle Connolly Top Hospital
Who is Dr. Kraemer, Endocrinologist in Stanford, CA?
Dr. Fredric Kraemer, MD is an Endocrinologist, who primarily practices in Stanford, CA with 2 additional practice locations. He has been practicing for over 45 years and is board certified. Dr. Kraemer graduated from New York University School of Medicine and completed his residency at Stanford Univ Hosp, Endocrinology, Diabetes & Metabolism; Kings County Hosp Ctr, Internal Medicine. Dr. Kraemer is fluent in English and Spanish, and is currently seeing new patients. Dr. Kraemer’s practice accepts Kaiser Permanente, Medicaid, Medicare, Aetna, Cigna, UnitedHealthcare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Kraemer’s office at (650) 493-5000.
What are Areas of Expertise for Dr. Kraemer?
Dr. Fredric Kraemer, MD is a highly-rated, board-certified Endocrinologist known for expertly diagnosing, treating, and managing a wide array of related conditions and procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Kraemer empowers patients to confidently navigate their health journey, specializing in Cholesterol/Lipid Disorders, Diabetes, and comprehensive wellness support. Serving the Stanford, CA community, Dr. Kraemer is dedicated to enhancing lives through expert, patient-centered care.
Where did Dr. Kraemer go to medical school and complete their residency?
Residency: Stanford Univ Hosp, Endocrinology, Diabetes & Metabolism; Kings County Hosp Ctr, Internal Medicine | Stanford University Program
Medical School: New York Univ Sch of Med, New York Ny | New York University School of Medicine
Is Dr. Kraemer board certified as an Endocrinologist?
Yes, Dr. Fredric Kraemer, MD is board certified by the American Board of Internal Medicine
What languages does Dr. Kraemer speak?
Dr. Kraemer and their clinical team can communicate with patients in the following languages:
English
Spanish
What conditions does an Endocrinologist like Dr. Kraemer typically treat?
As an Endocrinologist, Dr. Kraemer diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Kraemer. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.
Also known as:
- Type 1 Diabetes
- Type 1 Diabetes with Mild Eye Damage
- Diabetes Type 1
- Type 1 diabetes
- Diabetes Tests & Diagnosis
- Diabetic Eye Problems
- Juvenile Diabetes
- Insulin-Dependent Diabetes
- T1D
- Type 1 Diabetic Retinopathy
- Mild Nonproliferative Retinopathy
- Type 1 Diabetes Eye Disease
ICD-10 Codes:
- E109: Type 1 diabetes mellitus without complications
- E103293: Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, bilateral
Also known as:
- High Cholesterol
- Cholesterol
- Triglycerides
- Hypercholesterolemia
- High blood cholesterol
- Elevated cholesterol
- Hyperlipidemia
- High lipids
- Dyslipidemia
ICD-10 Codes:
- E7800: Pure hypercholesterolemia, unspecified
- E785: Hyperlipidemia, unspecified
Also known as:
- Type 2 Diabetes
- Diabetes Type 2
- Type 2 diabetes
- Diabetes Mellitus Type 2
- Adult-Onset Diabetes
- Non-Insulin Dependent Diabetes
ICD-10 Codes:
- E119: Type 2 diabetes mellitus without complications
What procedures does an Endocrinologist like Dr. Kraemer typically perform?
As an Endocrinologist, procedures performed by Dr. Fredric Kraemer may include:
- Adrenal Surgery
- Comparative Genomic Hybridization
- D and C / Vacuum Aspiration
- Diabetes Blood Sugar Management
- Diabetes Care - Kidney Disease Monitoring
- Diabetes Consultation
- Doppler Ultrasound
- Egg Freezing/ Fertility Preservation
Please contact Dr. Kraemer's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
Does Dr. Kraemer accept my insurance?
Dr. Kraemer accepts most major insurance plans. Important: Please call our office at (650) 493-5000 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Kraemer accept in Stanford, CA?
Dr. Kraemer in Stanford, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
Advantage
All Other Third Party
Blue Shield of California
Cigna Group
CVS Health (formerly Aetna)
Medicaid
Medicare
Santa Cruz County
State of California
UnitedHealth Group
View All Insurances
Where is Dr. Kraemer's office located?
Recognitions
Publications
Lipid droplet metabolism.
, 2013
Cholesterol ester droplets and steroidogenesis.
, 2013
Regulation of Expression and Function of Scavenger Receptor Class B, Type I (SR-BI) by +
, 2013
Mechanisms of Action of Hormone
, 2013
Hormone-sensitive lipase deficiency disturbs the fatty acid composition of mouse testis
, 2013
Fat-specific protein 27 modulates nuclear factor of activated T cells 5
, 2013
Age-related modulation of the effects of obesity on gene expression profiles of mouse bone marrow
, 2013
The mineralocorticoid receptor agonist, fludrocortisone
, 2013
Nordihydroguaiaretic acid improves metabolic dysregulation
, 2013
MicroRs 125a and 455 Repress Lipoprotein
, 2012
HSL-knockout mouse testis exhibits class B scavenger receptor upregulation
, 2012
Ablation of Vimentin Results in Defective Steroidogenesis
, 2012
Evidence for protein-mediated fatty acid efflux by adipocytes
, 2012
Lipid droplet meets a mitochondrial protein to regulate adipocyte lipolysis
, 2011
Hormone-sensitive lipase-knockout mice maintain high bone density during aging
, 2011
The role of lipid droplets in metabolic disease in rodents and humans
, 2011
Characterization of age-related gene expression profiling in bone marrow and epididymal adipocytes
, 2011
Hormone-sensitive lipase modulates adipose metabolism through PPAR gamma
, 2011
IL-17 Regulates Adipogenesis, Glucose Homeostasis, and Obesity
, 2010
Adipocytes Decrease Runx2 Expression in Osteoblastic Cells: Roles of PPAR gamma and Adiponectin
, 2010
Strong induction of PCSK9 gene expression through HNF1 alpha and SREBP2
, 2010
Vimentin Is a Functiol Partner of Hormone Sensitive Lipase And Facilitates Lipolysis
, 2010
Functiol interaction of hormone-sensitive lipase and perilipin in lipolysis
, 2009
Effects of hormone-sensitive lipase disruption on cardiac energy metabolism in response to fasting
, 2009
Identification of mR binding proteins that regulate the stability of LDL receptor mR through AU
, 2009
Cardiac overexpression of hormone-sensitive lipase inhibits myocardial steatosis
, 2008
Alysis of polymorphisms in the 3 ' untranslated region of the LDL receptor gene
, 2008
Transcriptiol activation of hepatic ACSL3
, 2007
Generation of novel adipocyte monolayer cultures from embryonic stem cells
, 2007
Adrel cholesterol utilization.
, 2007
Effects of rosightazone and high fat diet on lipase/esterase expression in adipose tissue
, 2007
The LDL receptor is not necessary for acute adrel steroidogenesis in mouse adrenocortical cells
, 2007
Control of adipose triglyceride lip
, 2007
Regulation of hormone-sensitive lipase in islets
, 2007
The medicil plant goldenseal is a tural LDL-lowering agent with multiple bioactive components
, 2006
Elucidation of an SRE-1
, 2006
Perilipin promotes hormone-sensitive lipase
, 2006
Hormone-sensitive lipase knockouts
, 2006
In vivo activities of cytokine oncostatin M in the regulation of plasma lipid levels
, 2005
Mutatiol alysis of the regulatory module of hormone-sensitive lipase
, 2005
Hormone-sensitive lipase is reduced in the adipose tissue of patients with type 2 diabetes mellitus
, 2005
Physical association between the adipocyte fatty acid-binding protein
, 2004
Function of hormone-sensitive lipase in diacylglycerol-protein kise C pathway
, 2004
Absence of hormone-sensitive lipase inhibits obesity and adipogenesis in Lep(ob/ob) mice
, 2004
Hormone-sensitive lipase is required for high
, 2004
Overexpression of leptin in transgenic mice leads to decreased basal lipolysis, PKA activity
, 2003
Lipase-selective functiol domains of perilipin A differentially regulate constitutive
, 2003
Resistance to high-fat diet-induced obesity
, 2003
Fatty acid-binding protein-hormone-sensitive lipase interaction - Fatty acid dependence on binding
, 2003
Angiotensin II activates cholesterol ester hydrolase
, 2003
Interaction of hormone-sensitive lipase with steroidogeneic acute regulatory protein
, 2003
Gender- and site-related effects on lipolytic capacity of rat white adipose tissue
, 2003
Sterol-mediated regulation of hormone-sensitive lipase in 3T3-L1 adipocytes
, 2003
Hormone-sensitive lipase
, 2002
Identification of Egr1 as the oncostatin M-induced transcription activator that binds to sterol
, 2002
Cardiac gene expression profile and lipid accumulation in response to starvation
, 2002
Effectiveness of diabetes magement: Is improvement feasible?
, 2002
Modulation of hormone-sensitive lipase
, 2002
Adrel neutral cholesteryl ester hydrolase: Identification, subcellular distribution
, 2002
Characterization of the functiol interaction of adipocyte lipid-binding protein with hormone
, 2001
Stimulation of lipolysis
, 2001
Mechanism of intracellular calcium ([Ca2+]i) inhibition of lipolysis in human adipocytes.
, 2001
Translocation of hormone-sensitive lipase
, 2001
Absence of cardiac lipid accumulation in transgenic mice with heart-specific HSL overexpression
, 2001
Mechanism of intracellular calcium ([Ca2+](i)) inhibition of lipolysis in human adipocytes
, 2001
Subcellular localization of insulin receptor substrate family proteins
, 2001
Requirement of sp1 and estrogen receptor alpha interaction in 17 beta-estradiol
, 2001
Impact of automated calls with nurse follow
, 2001
Oncostatin M-induced growth inhibition
, 2001
Human BMP-7/OP-1 induces the growth and differentiation of adipocytes and osteoblasts in bone
, 2001
Lipoprotein receptors, macrophages, and sphingomyelise
, 2000
Masoprocol decreases rat lipolytic activity by decreasing the phosphorylation of HSL
, 2000
Hormone-sensitive lipase functions as an oligomer
, 2000
Identification of a novel sterol
, 2000
Translocation of hormone-sensitive lipase
, 2000
Targeted disruption of hormone-sensitive lipase results in male sterility and adipocyte hypertrophy
, 2000
Do automated calls with nurse follow-up improve self-care
, 2000
Use of automated telephone disease magement calls in an ethnically diverse sample of low
, 1999
A unique mechanism of desensitization to lipolysis mediated by beta
, 1999
Interaction of rat hormone-sensitive lipase with adipocyte lipid-binding protein
, 1999
Induction of low density lipoprotein receptor
, 1999
Mutatiol alysis of structural features of rat hormone-sensitive lipase
, 1998
Insulin regulates lipoprotein lipase activity in rat adipose cells via wortmannin-
, 1998
Dietary regulation of the very low density lipoprotein receptor in mouse heart and fat
, 1997
Overexpression of hormone
, 1997
Retinyl ester hydrolysis and retinol efflux from BFC-1 beta adipocytes
, 1997
Down-regulation of hormone-sensitive lipase in sterol ester-laden J774.2 macrophages
, 1996
Alterations of lipolysis and lipoprotein lipase in chronically nicotine-treated rats
, 1996
Effects of streptozotocin
, 1996
Isoproterenol decreases LDL receptor expression in rat adipose cells
, 1996
Aberrations in normal systemic lipid metabolism in ovarian cancer patients
, 1996
Mechanism of anti-lipolytic action of acipimox in isolated rat adipocytes
, 1996
REGULATION OF HORMONE-SENSITIVE LIPASE IN STREPTOZOTOCIN-INDUCED DIABETIC RATS
, 1995
GENERATION OF ANTIBODIES AGAINST A HUMAN LIPOPROTEIN-LIPASE FUSION PROTEIN
, 1995
OVEREXPRESSION OF HORMONE-SENSITIVE LIPASE PREVENTS TRIGLYCERIDE ACCUMULATION IN ADIPOCYTES
, 1995
CHARACTERIZATION OF A PARTIALLY PURIFIED DIACYLGLYCEROL LIPASE FROM BOVINE AORTA
, 1995
Knowledge-based temporal abstraction in diabetes therapy.
, 1995
LOW-DENSITY-LIPOPROTEIN RECEPTORS IN RAT ADIPOSE-CELLS - SUBCELLULAR-LOCALIZATION AND REGULATION
, 1994
TRANSCRIPTIOL REGULATION OF LIPOPROTEIN-LIPASE IN THE HEART DURING DEVELOPMENT IN THE RAT
, 1994
DIFFERENCES IN HORMONE-SENSITIVE LIPASE EXPRESSION IN WHITE ADIPOSE
, 1994
REGULATION OF HORMONE-SENSITIVE LIPASE DURING FASTING
, 1994
LOW-DENSITY-LIPOPROTEIN RECEPTORS IN RAT ADIPOCYTES - REGULATION WITH FASTING
, 1994
KNOWLEDGE-BASED TEMPORAL ABSTRACTION FOR DIABETIC MONITORING
, 1994
THE RENIN-ANGIOTENSIN SYSTEM IN STREPTOZOTOCIN-INDUCED DIABETES-MELLITUS IN THE RAT
, 1993
DETECTION OF HORMONE
, 1993
DETECTION OF HORMONE
, 1993
REGULATION OF LIPOPROTEIN-LIPASE IN THE DIABETIC RAT
, 1992
ROLE OF LIPOPROTEIN-LIPASE AND APOLIPOPROTEIN
, 1992
DEVELOPMENTAL REGULATION OF LIPOPROTEIN-LIPASE IN RATS
, 1992
RESPONSIVENESS OF SUPERFICIAL HAND VEINS TO ALPHA-ADRENOCEPTOR AGONISTS IN INSULIN
, 1992
DEVELOPMENTAL REGULATION OF HORMONE-SENSITIVE LIPASE MESSENGER
, 1991
ELISA MEASUREMENT OF LDL RECEPTORS
, 1990
DIFFERENCES IN THE PROCESSING OF CHYLOMICRON REMNTS AND BETA-VLDL BY MACROPHAGES
, 1990
A MICROMETHOD FOR THE ISOLATION OF TOTAL R FROM ADIPOSE-TISSUE
, 1990
EFFECTS OF ACTIVATION ON LIPID AND LIPOPROTEIN METABOLISM IN MURINE MACROPHAGES
, 1990
PRORENIN AND VASCULAR COMPLICATIONS OF DIABETES
, 1989
REGULATION OF MACROPHAGE LIPOPROTEIN-LIPASE SECRETION BY THE SCAVENGER RECEPTOR
, 1988
INSULIN DEFICIENCY DECREASES LIPOPROTEIN-LIPASE SECRETION BY MURINE MACROPHAGES
, 1988
THE REGULATION OF HYDROXYMETHYLGLUTARYL-COA REDUCTASE IN CULTURED-CELLS
, 1988
MICROALBUMINURIA AND INCREASED PLASMA PRORENIN - PREVALENCE IN DIABETICS FOLLOWED UP FOR 4 YEARS
, 1988
MECHANISM OF HALOTHANE-INDUCED INHIBITION OF ISOPROTERENOL
, 1988
DIABETES AND LIPOPROTEIN RECEPTORS
, 1987
TRANSPORT OF BETA-VERY LOW
, 1987
REGULATION OF THE SECRETION OF LIPOPROTEIN-LIPASE BY MOUSE MACROPHAGES
, 1986
MILK-ALKALI SYNDROME IN PATIENTS TREATED WITH CALCIUM-CARBOTE AFTER CARDIAC TRANSPLANTATION
, 1986
EVIDENCE THAT CHYLOMICRON REMNTS AND BETA
, 1986
EFFECTS OF ACTIVATION ON LIPOPROTEIN-LIPASE SECRETION BY MACROPHAGES - EVIDENCE FOR AUTOREGULATION
, 1986
EFFECTS OF KETOCOZOLE ON CHOLESTEROL-SYNTHESIS
, 1986
INSULIN DEFICIENCY ALTERS CELLULAR CHOLESTEROL-METABOLISM IN MURINE MACROPHAGES
, 1986
INHIBITION OF CHOLESTEROL-SYNTHESIS BY KETOCOZOLE
, 1986
EFFECTS OF NONINSULIN-DEPENDENT DIABETES
, 1985
INCREASED PLASMA ICTIVE RENIN IN DIABETES-MELLITUS - A MARKER OF MICROVASCULAR COMPLICATIONS
, 1985
ACROMEGALY AND ZOLLINGER-ELLISON SYNDROME SECONDARY TO AN ISLET CELL TUMOR
, 1984
Characterization of the binding site on thioglycolate
, 1983
ARE THE BINDING AND DEGRADATION OF LOW-DENSITY LIPOPROTEIN ALTERED IN TYPE-2
, 1982
HYPERTRIGLYCERIDEMIA AND LIPOPROTEIN-LIPASE ACTIVITY IN EXPERIMENTAL UREMIA
What is Dr. Kraemer's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Kraemer's National Provider Identifier (NPI) number is 1780796037.
What common questions do patients ask about Dr. Kraemer?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Kraemer
What is Dr. Fredric Kraemer's specialty?
Dr. Kraemer is a Endocrinologist near Stanford, CA.
What does an Endocrinologist do?
An internist specializing in disorders of the endocrine glands, including the thyroid and adrenal glands. This specialist also manages a range of conditions such as diabetes, metabolic and nutritional disorders, obesity, pituitary disorders, and menstrual and sexual health issues.
Is this Dr. Fredric Kraemer affiliated with a ranked Castle Connolly Top Hospital?
Yes, Dr. Kraemer is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
When to see an Endocrinologist?: Guides for symptoms, conditions, and treatments
Understand your symptoms and know when it’s time to see an Endocrinologist. Explore insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is Fredric Kraemer accepting new patients in Stanford, CA?
Yes, Dr. Fredric Kraemer is accepting new patients at this time.
Does Dr. Fredric Kraemer offer online booking?
Please contact Dr. Kraemer's office at (650) 493-5000 for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with Fredric Kraemer?
Please contact Dr. Kraemer's office at (650) 493-5000 for information regarding telehealth appointment availability or for scheduling assistance.
Which board certifications does Dr. Fredric Kraemer have?
Dr. Fredric Kraemer is certified by the American Board of Internal Medicine.
Other Endocrinologist Near Stanford, CA
Endocrinologist
Accepting patientsEndocrinologist
Accepting patients
Endocrinologist
Accepting patients